chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Nov.30,2021- vaccine dose 1. fatigue/ soreness and bleeding from injection site(L arm).-.  Dec.1,2021-  vaccine dose 2. I had no issues. I was walking across a yard and my stomach started to hurt. Before I got 12 steps, i became sob with heart palpitations. I took my Metoprolol 25mg. I was wet from sweating. But gagging and nauseated. I would gag yet this hurt my chest. I then became so dizzy i had to lay in the bathroom floor. I was shaking with chills and teeth chattering. I was alone and could not get to my phone. I slept in the bathroom floor for 3 hours. Woke up. Slow position change to sit up with the dizziness. I was able top sit a few mins. and then to stand to get to my phone. I wasn't sure what was wrong. I could not stop sneezing, continuously. BOXES of tissues were used during a short time frame. My head hurt. Runny nose. A relative stopped by and stated they would be near by if needed. These symptoms lasted until 12/03. On 12/03, I still have moments of dizzy and nauseated. NOW,my face is sore/ swollen. Puffy... on 12/06 I can look down and see my cheek. By 12/07 ONLY the left side of my body is swollen. Mostly my face. I went by the Pharmacy who states it appears to be an allergic reaction and has recommended I take Benadryl and f/u so that this is added to my medical record. At this time i am swollen, oddly a numb/ asleep feeling to different areas. Mainly finger tips. I am concerned. I will attempt benadryl.
Throbbing pain in my left hand, particularly between my thumb and forefinger, and general weakness when grabbing.  Gradually getting better.
PATIENT PRESENTED TO PHARMACY WITH AN APPOINTMENT FOR MODERNA DOSE 1. PATIENT COMPLETED PAPERWORK INDICATING NO PRIOR COVID VACCINE. PATIENT VERBALLY CONFIRMED THIS WAS FIRST DOSE OF ANY COVID VACCINE. AFTER PATIENT LEFT PHARMACY, IT WAS DISCOVERED THAT SHE HAD RECEIVED MODERNA COVID-19 VACCINE 15 DAYS PRIOR ON 4/14/2021 AT ANOTHER PHARMACY.
Suspected vaccination failure; shingles; Scar; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an adult patient who received Herpes zoster (Shingle's vaccine).   Co-suspect products included Herpes zoster (Shingle's vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles 4 years ago from the day of reporting).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingle's vaccine. On an unknown date, unknown after receiving Shingle's vaccine and Shingle's vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and scar. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the vaccination failure, shingles and scar were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and scar to be related to Shingle's vaccine. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingle's vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication. The patient took the shot and would not wish them on his or her worse friend, they were terrible and did leave scars just like chicken pox do. This case was considered as suspected vaccination failure as details regarding time to onset for target disease (shingles) and laboratory confirmation were unknown at the time of reporting. The reporter stated that 2 of his or her sisters did not take them but 1 and he or she, did a slept in the same bed till mamma had to make him or her a bed in a chair away from the other kids. The patient had them so bad than the shingles 4 years ago. This case had been linked with the case- US2021AMR077311 and US2021AMR077319, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR077319: same reporter
Two weeks after vaccine I Had a late onset  rash that  traveled within time started on my ankles, then behind knees and back of thighs and inner thighs, then to lower and upper abdomen,  then to braline and  lower chest, then elbows  and wrists.  It itched terribly.  It came up in red patches with bumps when scratched.  I had tried hydrocortisone and antifungal, and showered daily.   No relief.  After trying to take care of it at home for over a month, I went to convenient MD and begged for a steriod cream.   I have not had a rash like this before.    With the steriod cream the rash slowly went away.  I had to use three tubes and multiple small amounts as it was all over my body.
I21.4 - Non-ST elevation (NSTEMI) myocardial infarction N17.9 - Acute kidney failure, unspecified
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore Arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Heart disease, unspecified and Aneurysm of artery of lower extremity. Concomitant products included TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for Lung disease, CELECOXIB (CELEXA [CELECOXIB]) and CLONAZEPAM (KLONOPIN) for Panic attacks, OXYGEN, TRIAMTERENE and CYANOCOBALAMIN (B-12) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore Arm). At the time of the report, MYALGIA (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported inhaler as concomitant medication. No treatment medications were reported    This case was linked to MOD-2021-038509 (Patient Link).
Left shoulder 11/25 given seasonal influenza vaccine by ER manager to left deltoid high on the deltoid.  Severe pain with injection.  Pain progressively getting worse x3 weeks with decreased ROM. As of 12/11/14 unable to lift left arm up to do my hair.  To date pain unrelieved by Motrin and Voltaren cream. 12/11/14 Notified employee health and risk manager of symptoms and pain from vaccine adverse reaction. No forms filled out. Discussed with ER manager my symptoms and pain.  Per ER manager she too thought she had given the vaccine high up on my deltoid. X-ray 4view left shoulder order by Dr. was normal. MRI without contrast left shoulder was order by Dr. showing edema in the supraspinatus and infraspinatus muscle bodies left shoulder. US left shoulder (quick view) performed no report Consult with Dr. and exam by Dr.  Followed by Kenalog injection to left shoulder which provided minimal relief. Arranged fu appt for 12/12/14 with Dr.  Placed on Medrol dose pak and Aleve. Pain 8/10 at night 12/11/14 causing me not to be able to sleep. Unable to fully perform job duties, care for my young children 12/12/14.
High fever 103.5 5 days diarrhea  19 days in bed 7 days
GOT SICK; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced got sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got sick was not reported. This report was non-serious.
pt recv vax 13SEP95 & 12FEB97 pt devel a mild case of chickenpox;@ the time of the report, there were 20 spots;
Patient received her second Pfizer COVID vaccine at 3:29 pm this afternoon.  At 3:40 pm, she stated complaining of not feeling well, having a metallic taste, and having the feeling of pins and needles in her mouth.  VS were taken at 3:41 with BP 169/92, HR 90, and O2 Sat of 100%.  VS were taken again at 3:45 with BP 169/98, HR 86, and O2 Sat 98%.  It was determined with increased BP that EMS be called to further assess patient.  EMS arrived at 4:04 to assess patient.  Manual BP at that time was 200/120.  EMS offered to transport patient to  for further evaluation, but patient refused transport and stated she wanted to go home to see if her BP would decrease some.  Staff encouraged patient to have someone pick her up from the site instead of patient trying to drive herself home.  Patient was discharged home in the care of her son and instructed to call 911 for any further or worsening of symptoms with verbalization of understanding and agreement.
9/9/2021 Sore throat, headache, nasal congestion, loss of smell & taste. Used over the counter cold liquid and ibuprofen. Symptoms subsided about 6 days later
temp 39.9 rectal, inconsolable crying large indurated red area over thigh of vax 8x5cm-all w/in 4hr;
Upper body scattered papular rash a few days after vaccinations and also developed a dark area I (R) thigh. visit was on 5/20/19 and was Wnl 10 days prior
14 days post COVID positive test received 1st shot,14 days post Monoclonal antibody infusion received 1st shot; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (14 days post COVID positive test received 1st shot,14 days post Monoclonal antibody infusion received 1st shot) in a 19-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (After vaccination, he told the pharmacist that he was COVID positive).    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (14 days post COVID positive test received 1st shot,14 days post Monoclonal antibody infusion received 1st shot). On 04-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (14 days post COVID positive test received 1st shot,14 days post Monoclonal antibody infusion received 1st shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and Treatment was not specified. Patient stated that after vaccination, he told the pharmacist that he was COVID positive and received Monoclonal antibodies 14 days ago.
On 02/18/2021, I started noticing, my blood sugar went extremely elevated, It fluctuated 260ish for a month and it was not coming down. Prior to the vaccination my A1c was about 6.3. I had very controlled blood sugars. I also had a high fever of 102 for about 2 day. I had to change my medication went to see the doctor around the end of March. I was doing really well on the medication prior to the vaccine. The new medication, Ozempic was added on to the medication I was already taking which was Glumetza. The new medication I am taking is helping, I was having extreme abdominal pain with the new medication, so many side effects that I don't know if I can continue taking it. It is unknown if I have recovered from the AE's because if they took me off the Ozempic, I don't know what my blood sugars would do.
PT RECEIVED 1ST DOSE PFIZER ON 4/17/21, PT SCHEDULED FOR 2ND DOSE PFIZER ON 5/2. PT WAS VACCINATED (WAS GIVEN DOSE 6 DAYS EARLY). CLINIC LEAD, CLINIC SUP AND MONITORING SUP MADE AWARE. OBSERVATION FOR 30 MINS. PT ASYMTOMATIC.
severe allergic reaction; started out on my top tip swelling up an the bottom of my feet an the palm of my hand swelling; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (severe allergic reaction) and PERIPHERAL SWELLING (started out on my top tip swelling up an the bottom of my feet an the palm of my hand swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (severe allergic reaction) and PERIPHERAL SWELLING (started out on my top tip swelling up an the bottom of my feet an the palm of my hand swelling). At the time of the report, HYPERSENSITIVITY (severe allergic reaction) and PERIPHERAL SWELLING (started out on my top tip swelling up an the bottom of my feet an the palm of my hand swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Had the expected side effects of arm pain, body aches, headache and chills beginning several hours after vaccination. The morning after the vaccination, I felt like I would be okay to go to work, so got up to take a shower.  Felt very lightheaded in the shower and fainted.  Fell to the floor outside the shower, hitting my head on the tile floor.  Was later able to proceed with going to work.  No other ill effects or treatment.
12:30 PM - Administered Pentacel, Varivax, Havrix, and MMR (order of administration). Within approx two minutes, child began rubbing eyes and grabbing ears. Mother noticed bumps on face and stated child's eyelids and nose were swollen. Upon examination, eyes and ears were swollen, hives were present on torso, legs and arms. feet and hands also swollen. No respiratory distress was not present. Lungs clear. pediatrician notofied. 2.5 ml of benadryl (625 mg) given per order. pediatrician to arrange appt with allergist. Mother spoke with Pediatrician's office for further instructions. left clinic at 1:05 PM in no distress and improvement after benadryl.
This spontaneous report was received from a healthcare worker refers to an unspecified patients of unknown age and gender. The patient's medical history and concurrent conditions and concomitant medications were not specified. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL lot # K007264, expiry date 02-MAR-2017, (dose and frequency not reported). No adverse experiences were reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Upper left arm opposite shot site erupted in rash. Then noticed rash on forearms on both arms, worse on left arm. Few days later rash on side of left knee, then right hip, then left ankle.
PATIENT EXPERIENCED DIZZINESS AND LIGHTHEADEDNESS AND BECAME UNCONCIOUS FOR A FEW MOMENTS
Patient is a 36 yo female with history of IVDU, Hep C, fibromyalgia who presents with left leg pain and swelling found to have significant left leg DVT now s/p femoropopliteal vein thrombectomy.   HPI:  Patient is a 36 y.o. female with history of IVDU, Hep C, fibromyalgia who presents with left leg pain and swelling.   Patient woke up this morning with her entire left leg being painful, swollen, "tight", and "achy" throughout. She had been experiencing 1 week of left leg pain, followed by an acute worsening in the last 2 days. She denies any recent travel or leg trauma.   She denied any fevers, chills, SOB, or chest pain. She denies any new tattoos, recent malignancies, or blood clotting disorders. Of note, she is currently undergoing evaluation for lupus due to fatigue and rashes.   Per her IVDU, she injects heroin in her arm (last use 1 month ago after 4 years of sobriety), and is currently on methadone. This pain is different from her fibromyalgia.   Of note, she got her first Moderna COVID vaccine last week.     Highlights of ED course: Pertinent exam findings: tachycardia, marked LLE swelling (mid thigh 70 cm vs 64 cm on RLE) Warm bilateral LE, palpable pulses Important data gathered: LENI: left deep vein thrombosis extending from common femoral vein to distal posterior tibial veins, ESR 47, CRP 58, elevated d-dimer > 4000 Key treatments administered: heparin gtt, oxyodone 5 mg for pain, vascular medicine, cardiology consult   Patient was subsequently evaluated by vascular medicine, who brought her to cath lab for venography and endovenous intervention. She went to the cath lab. U/s guided access to L popliteal vein with micropuncture. J-wire into L CIV, serial dilation and placement of 12F sheath. Multiple passess with Penumbra lightning aspiration catheter. Femoropopliteal vein with restored patency, continued organized clot in iliac vein, infusion of 6mg TPA with 10 min dwell time. Further passages of aspiration catheter. Decision to leave 30 cm infusion cath.    When seen on the floor, patient was hemodynamically stable. Still with pain in lower extremities and back. No chest pain or SOB.     #DVT, s/p vascular surgery thrombectomy 2 days of acute left leg pain and swelling. Initial exam notable for purplish LLE in ED. LENIs notable for left DVT extending from CF vein to distal PT veins. Vascular evaluated and performed femoropopliteal vein thrombectomy with restored patency, continued organized clot in iliac vein, infusion of 6mg TPA with 10 min dwell time. Further passages of aspiration catheter. Decision to leave 30 cm infusion cath. On OCPs but no known other risk factors (quit smoking), suggesting unprovoked DVT. Other potential etiology includes venous congestion. Hypercoaguable w/u pending. Notably, Moderna vaccine 1 week ago, although limited evidence suggesting relation between mRNA vaccine and increased thrombosis risk. Hypercoagulability workup was sent. Patient transitioned from heparin to apixaban for discharge with vascular medicine and vascular surgery followup
When attempting to sit up in bed, I was overcome by vertigo/dizziness followed by nausea & vomiting.  Acute symptoms lasted about 60 minutes followed by several hours of sleep.  As of 1 pm, 02/06/2015, I still have an abnormal feeling in the back of my head toward the nape of my neck.  I am able to eat and drink without problem.
Caller states her thyroid test results came back spiked; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient would like to know if the Pfizer COVID vaccine would affect the results of blood work for a thyroid test. The patient stated that her thyroid test results came back spiked on an unspecified date. The outcome of the event was unknown.  Information on lot number/batch number has been requested.
Wasn't feeling well; Shingles; This is a spontaneous report from a contactable consumer. This 39 year-old non-pregnant female consumer (Patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL0142) via an unspecified route of administration on 05Jan2021 at 04;30 PM (at 39-year-old) in left arm as dose 1, single for COVID-19 immunization. The patient had no medical history and no allergies. The patient received Healther birth control pills in two weeks. It was mentioned that no other vaccine was received in four weeks, the patient did not have Covid prior vaccination and was not tested for covid post vaccination. Two weeks after the first dose on 20Jan2021 at 01:00 pm patient was not feeling well and went to (withheld) Urgent Care and was diagnosed with Shingles. She had never had Shingles and also did not have any underlying illnesses. The event resulted in emergency room visit. She was treated with Valtrex for events. On an unknown date in 2021 the patient recovered.  No follow-up attempts were possible. No further information was expected.
Narrative: Patient is 82 year old MALE CAD s/p CABG, DM 2, hypertension, hyperlipidemia, returns to the emergency room for the third time in 10 days for evaluation of worsening shortness of breath, cough, and fever. He was evaluated in our emergency department and found to have COVID-19 infection on July 3, 2021 and treated with albuterol MDI. He returned on July 9 and was prescribed Augmentin and azithromycin for pneumonia. Despite these measures he continues to feel ill. His appetite has been poor and he gets very "winded" with minimal activity. Cough is been productive of whitish yellow sputum. Denies any chest pain. Denies any nausea, vomiting or diarrhea. Denies any taste or smell loss. In the emergency room, ambulatory O2 saturation was down to 86% HOSPITAL COURSE: The patient was admitted to the medical floor and placed on COVID isolation precautions. Sepsis treated with IV fluids and empiric antibiotics. He was also started on remdesivir and dexamethasone per protocols for COVID pneumonia with hypoxic respiratory failure. Patient transferred to the ICU for increased oxygen requirements and remained in the ICU until 7/21 with O2 requirements as high as 15L on non-rebreather. Patient completed a course of dexamethasone and remdesivir. He was transferred to the medical floor on 7/21 and treatment continued. Oxygen was weaned to room air. Steroid-induced hyperglycemia treated with basal-bolus insulin which was discontinued once steroids were completed and blood glucose normalized. Patient developed hyponatremia, with urine studies consistent with SIADH. He initially did not improve with fluid restriction and salt tablets were started with eventual improvement in serum sodium. CONDITION AT DISCHARGE: At the time of discharge, patient was hemodynamically stable and afebrile. He was able to ambulate independently and did not require the use of supplemental oxygen. Sodium was 131 and patient agreeable to continued close monitoring of labs outpatient.
On the 2nd day developed high fever up to 102 F, sever headache on the back of head with muscle weakness in neck on the right side in particular , on 09/03 day developed  UTI for 5 day sever ( had appointment 09/07 with primary),  on the 10th day started to experience tingling in both legs from hip down  ankle with firing nerve pain ( wasn't able to sleep and rest at night time), at the same time had palpitations in the heart and hard time to control blood pressure( have a log of BP up to 159/85 with HR 94 at rest),  5 days later tingling in legs went down from knees to ankles. at day 28 all symptoms  diminished.
Chest pain, increased BPM, wild fluctuations in blood pressure at times, for the whole week following vaccination. Way outside the "normal" range of previous manifestations of atrial fibrillation.